Ask AI
ProCE Banner Activity

RELATIVITY: LA CAB + RPV Effectiveness in People Living With HIV and Non-RPV NNRTI Resistance Mutations

Conference Coverage
Slideset

This retrospective analysis of a real-world, multisite Spanish cohort of people living with virologically suppressed HIV who switched to LA CAB + RPV assessed the impact of non-RPV NNRTI RAMs. Investigators reported high levels of virologic suppression and no increase in virologic failure rate among people with non-RPV NNRTI RAMs.

Released: November 16, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions